Arcede Pharma is a pharmaceutical company. The company conducts research and development in the area of chronic obstructive pulmonary disease, including abbreviated COPD, and severe asthma. The company's product portfolio includes a number of drugs intended for the treatment and alleviation of the above ailments. The largest operations are in the Nordic market. The company was established via a spin-off of Respiratorius in 2022 and is headquartered in Lund.

Quotes for Arcede Pharma AB

Right Now

+/-
0.14
%
6,48%
Latest
2.3
High
2.38
Low
2.14
Volume
16 779
Turnover (SEK)
38 286
Market Value (MSEK)
13,4
Time (Latest trade)

Board

CEO

  • Mia Lundblad

Chairperson of the Board

  • Ingemar Kihlström

Board

  • Åsa Kornfeld
  • Johanna Asklin
  • Laurent Pacheco

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 10,34 10,34 2022-06-29
Avanza Pension 7,78 7,78 2022-06-29
Valcuria Holding AB 5,10 5,10 2022-06-29
Ben Hayes 2,34 2,34 2022-06-29
Hans Harvig 2,24 2,24 2022-06-29
Wilhelm Risberg 1,58 1,58 2022-06-28
Fredrik Lundgren 1,52 1,52 2022-06-28
Benny Bengtsson 1,30 1,30 2022-06-29
Göran Lennart Rehn 0,99 0,99 2022-06-28
Hartmut Wiese 0,99 0,99 2022-06-29
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Upcoming reports

  • 2022-09-23 Delårsrapport 2023-Q1

  • 2022-12-05 Delårsrapport 2023-Q2

  • 2023-05-12 Årsstämma 2023

Annual reports, prospectus etc.